Atlas Trials

The Efficacy and Safety of Pola-ZR-Glo in Older Treatment-naive Patients With LBCL

Clinical trial NCT07514169 · RECRUITING

Trial details

NCT number
NCT07514169
Sponsor
Ruijin Hospital
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Large B-Cell Lymphoma (LBCL)
Start date
2026-03-31
Primary completion
2028-12-31
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.